Discrepancies in dose and dose specification in interstitial implants | JoVE Visualize

Discrepancies in dose and dose specification in interstitial implants

J M Burgers¹, H K Awwad, R van der Laarse

¹Department of Radiotherapy, The Netherlands Cancer Institute (Antoni von Leeuwenhoekhuis), Amsterdam.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1988

View abstract on PubMed

Summary

Interstitial implant systems like Paterson-Parker and Paris offer guidance for source arrangement and dose calculation. However, deviations from these rules can lead to significant dose rate variations, impacting treatment accuracy.

Area of Science:

Medical Physics
Radiation Oncology
Brachytherapy

Background:

Interstitial brachytherapy requires precise source arrangement for effective target volume coverage.
Established implant systems (e.g., Paterson-Parker, Paris) provide guidelines for source placement and dose calculation.
Variations in source arrangement can lead to different reference dose rates for the same target volume.

Purpose of the Study:

To investigate the discrepancies between predicted and computer-calculated dose rates in interstitial implants.
To analyze the impact of deviations from standard implant system rules on dose delivery.
To quantify dose rate changes and identify locations of deviation in clinical scenarios.

Main Methods:

Comparison of predicted reference dose rates with computer-calculated dose rates for theoretical interstitial implants.
Analysis of dose rate variations under moderate digressions from established implant system rules.
Quantification of dose rate changes exceeding 10% and their spatial distribution.

Main Results:

Discrepancies between predicted and calculated dose rates increase with deviations from implant system rules.
Significant dose rate changes (over 10%) were observed and localized in theoretical implant examples.
Clinical deviations from standard protocols can commonly lead to unpredictable dose variations.

Conclusions:

Adherence to established interstitial implant system rules is crucial for accurate dose delivery.
Clinicians must be aware of potential dose variations resulting from deviations in source arrangement.
Understanding these variations is essential for optimizing interstitial brachytherapy outcomes.